Biokapital- R&D
     
Henriette Kise (left) and Nils Christian Steig (right)
24.08.11

New management in SpermVital AS

Effective 1st November, Nils Christian Steig will be the new Managing Director, and Henriette Kise will be Sales and Marketing Director of SpermVital AS.

 

The combined experience of the new leader duo will benefit the growth of the company as they enter the exciting phase of commercialization of the SpermVital technology internationally.

 

Nils Christian Steig (49), the new Managing Director of SpermVital AS, is originally from Hundorp, Norway. He comes to SpermVital from a position as factory manager at Isoterm AS in Ringebu, Norway. He holds an MSc in Economics and Business Administration and has broad industrial experience from management, international sales and marketing.

 

Henriette Kise (37), the new Sales and Marketing Director, brings to the table 17 years of experience from marketing and development of ProEthic Pharmaceuticals in the USA. She was responsible for marketing and sales of Proethic Pharmaceuticals' products in Alabama and Georgia. She is originally from Lillehammer, Norway.

 

Research and development continues with intensified focus on further improvement of the SpermVital technology and documentation of the fertility of SpermVital semen on other cattle breeds, including Holstein. Results from these trials are expected spring 2012.

Print RSS
      | More
BioKapital AS, Holsetgata 22, N-2317 Hamar, Norway Phone: +47 950 20 600 Fax: +47 62 52 06 01
E-mail: post@biokapital.no
VAT Reg. 993130532
 
Infoboks